Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb

WEDNESDAY, Sept. 5, 2018 -- Under Medicare Part D, out-of-pocket costs are similar for infliximab and its biosimilar infliximab-dyyb, according to a research letter published in the Sept. 4 issue of the Journal of the American Medical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news